| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.30B | -21.6% |
| Gross profit | ¥0.41B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.02B | -73.7% |
| Gross margin | 31.4% | Net margin 1.6% |
| Revenue Q/Q | -26.0% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.89B | 68.6% |
| R&D | ¥0.08B | 6.2% |
| SG&A | ¥0.29B | 22.6% |
| Tax & other | ¥0.02B | 1.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
三诺生物 ・ 富春股份 ・ 海峡创新 ・ ST长方 ・ 同有科技 ・ 聚飞光电 ・ 云意电气 ・ 裕兴股份 ・ 远方信息 ・ 慈星股份 ・ 宜通世纪 ・ ST任子行
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies